Winton Capital »

Xeris Pharmaceuticals shares owned by Winton Capital

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Winton Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $739k 91k 8.14

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ge Vernova (GEV)
Select Sector Spdr Tr Sbi Materials (XLB)
Devon Energy Corporation (DVN)
Interactive Brokers Group In Com Cl A (IBKR)
Meta Platforms Cl A (META)
Uber Technologies (UBER)
Fastenal Company (FAST)
Incyte Corporation (INCY)
Masco Corporation (MAS)
Five Below (FIVE)
Johnson Ctls Intl SHS (JCI)

View all positions for Winton Capital

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
D. E. Shaw & Co
Geode Capital Management
State Street Corporation
Morgan Stanley
Qube Research & Technologies
Nuveen
Driehaus Capital Management
Rosalind Advisors
Goldman Sachs Group
Parkman Healthcare Partners
UBS Group
Connor, Clark & Lunn Investment Management
Renaissance Technologies

View all funds holding Xeris Pharmaceuticals